UPDATE 1-Merck's Keytruda wins FDA approval to treat head and neck cancer
June 11, 2019 at 07:12 AM EDT
Merck & Co Inc said on Tuesday its blockbuster cancer drug Keytruda won approval from the U.S. Food and Drug Administration to treat a type of head and neck cancer.
